{"SPADE_UN_25094": {"basic": {"SPADE ID": "SPADE_UN_25094", "Peptide Name": "NK-2, NK-lysin (39-65)", "Sequence": "KILRGVCKKIMRTFLRRISKDILTGKK", "Source": "", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antiparasitic", "Anticancer", "Anti-Mammalian Cell"], "Target Organism": "Staphylococcus aureus SA113(MIC=32µg/ml),Staphylococcus aureus SA113(MIC=>256µg/ml),Staphylococcus aureus SA113(MBC=256µg/ml),Staphylococcus aureus SA113(MBC=>256µg/ml),Staphylococcus aureus Del-mprF(MIC=8µg/ml),Staphylococcus aureus Del-mprF(MIC=8µg/ml),Staphylococcus aureus Del-mprF(MBC=16µg/ml),Staphylococcus aureus Del-mprF(MBC=16µg/ml),Staphylococcus aureus Del-mprFpRBsyn(MIC=8µg/ml),Staphylococcus aureus Del-mprFpRBsyn(MIC=8µg/ml),Staphylococcus aureus Del-mprFpRBsyn(MBC=16µg/ml),Staphylococcus aureus Del-mprFpRBsyn(MBC=16µg/ml),Staphylococcus aureus(MIC=64µg/ml),Staphylococcus aureus(MIC=64µg/ml),Staphylococcus aureus(MBC=128µg/ml),Staphylococcus aureus(MBC=128µg/ml),Escherichia coli ATCC 25922(MIC=16µg/ml),Acinetobacter baumannii ATCC 19606(MIC=2µg/ml),Bordetella bronchiseptica CUN 11844-99(MIC=4µg/ml),Brucella abortus 9.49 (per-)(MIC=32µg/ml),Pseudomonas aeruginosa CUN 4158-02(MIC=32µg/ml),Yersinia pestis KIM pYV(MIC=>256µg/ml),Staphylococcus aureus ATCC 43300(MIC=256µg/ml),Escherichia coli ATCC 23716(MIC=0.25µg/ml),Escherichia coli ATCC 23716(MIC=16µg/ml),Human cervical carcinoma HeLa(30-40% Cytotoxicity=100µg/ml),Plasmodium falciparum(LC50=6.2µM),Mycobacterium smegmatis(70-80% Killing=30µM),Mycobacterium bovis BCG(80-90% Killing=30µM),Human histiocytic lymphoma U-937(LD50=30µM),Human colon adenocarcinoma SW480(LD50=1-4µM),Human myelogenous leukemia K562(LD50=1-4µM),Human neuroblastoma LA-N-1(LD50=1-4µM),Human neuroblastoma SH-SY5Y(LD50=1-4µM),Escherichia coli ATCC 25922(MBC=16µg/ml),Acinetobacter baumannii ATCC 19606(MBC=2µg/ml),Bordetella bronchiseptica CUN 11844-99(MBC=4µg/ml),Brucella abortus 9.49 (per-)(MBC=32µg/ml),Pseudomonas aeruginosa CUN 4158-02(MBC=32µg/ml),Yersinia pestis KIM pYV(MBC=>256µg/ml),Staphylococcus aureus ATCC 43300(MBC=256µg/ml),Escherichia coli ATCC 23716(MBC=0.25µg/ml),Escherichia coli ATCC 23716(MBC=32µg/ml),Mycobacterium smegmatis mc2-155(no activity data),Mycobacterium smegmatis mc2-155(MBC90=17.5µg/ml),Mycobacterium marinum ATCC 927(MBC90=3.5µg/ml),Murine macrophage cells RAW 264.7(no activity data),Human breast adenocarcinoma MCF-7(EC50=30±3µM),Escherichia coli CMCC 44102(MIC=4µM),Pseudomonas aeruginosa ATCC 27853(MIC=8µM),Staphylococcus aureus CMCC 26003(MIC=2µM),Staphylococcus epidermidis ATCC 12228(MIC=2µM),Human bladder cancer BIU-87(IC50=25µM),Human bladder cancer EJ(IC50=10µM),Human prostate adenocarcinoma PC-3(IC50=5µM),Human bladder carcinoma T24(IC50=12µM),Human promyelocytic leukemia HL-60(IC50=15µM),Human myelogenous leukemia K562(IC50=>50µM)", "Sequence Length": 27}, "extended_data_url": "SPADE_UN_25094_extended.json"}}